BREAKING HTLV-I LATENCY: P30-RNA INTERACTIONS A NOVEL THERAPEUTIC TARGET

$72,904P20FY2005RRNIH

University Of Kansas Medical Center, Kansas City KS

Investigators

Christophe P Nicot

Linked publications & trials

Paper 38973385 Paper 37047307 Paper 36982817 Paper 34206989 Paper 32094348 Paper 31786131 Paper 31608135 Paper 28631436 Paper 27599865 Paper 26673007 Paper 25979221 Paper 25417703 Paper 24718901 Paper 24688053 Paper 24648462 Paper 24623409 Paper 24049177 Paper 24025737 Paper 23738670 Paper 23534410 Paper 23215679 Paper 23129310 Paper 23027537 Paper 22869732 Paper 22452361 Paper 22387218 Paper 22334704 Paper 22334419 Paper 22210333 Paper 21984960 Paper 21738525 Paper 21718728 Paper 21698228 Paper 21680529 Paper 21622561 Paper 21557737 Paper 21473630 Paper 21411729 Paper 21399639 Paper 21375342 Paper 21374602 Paper 21331319 Paper 21296889 Paper 21293096 Paper 21254383 Paper 21159861 Paper 21151930 Paper 21148236 Paper 21047968 Paper 20978129 Paper 20922813 Paper 20889506 Paper 20861249 Paper 20844026 Paper 20618153 Paper 20575527 Paper 20457462 Paper 20452974 Paper 20413852 Paper 20335259 Paper 20303585 Paper 20214960 Paper 20164193 Paper 20159967 Paper 20046918 Paper 20041225 Paper 19958949 Paper 19923181 Paper 19911425 Paper 19883077 Paper 19861680 Paper 19805541 Paper 19789962 Paper 19758996 Paper 19758675 Paper 19743894 Paper 19741006 Paper 19684130 Paper 19587029 Paper 19526482 Paper 19515767 Paper 19479051 Paper 19462331 Paper 19429421 Paper 19415471 Paper 19393662 Paper 19386275 Paper 19353639 Paper 19337995 Paper 19283490 Paper 19233849 Paper 19211873 Paper 19211770 Paper 19015016 Paper 18986665 Paper 18973553 Paper 18959432 Paper 18927073 Paper 18802075 Paper 18797513

View original record on NIH RePORTER →

BREAKING HTLV-I LATENCY: P30-RNA INTERACTIONS A NOVEL THERAPEUTIC TARGET · GrantIndex